Adenosine and chronic ischemia of the lower limbs.
Adenosine is an endogenous nucleoside with multiple biological properties which plays a central role in the pathophysiology of tissue ischemia. Adenosine signals an imbalance between oxygen demand and supply, and it initiates responses to redress such a discrepancy. Besides its vasodilating properties, adenosine possesses anti-platelet and anti-neutrophil activities and provides cytoprotection. Adenosine is presumably the main mediator of the preconditioning phenomenon. During ischemia of the lower limbs, adenosine plays a physiological role by inducing vasodilatation and by preventing microcirculatory failure. Exercise training prolongs claudication distance possibly by inducing pulse increases of adenosine and consequently skeletal muscle preconditioning. Moreover, the adenosine increase which follows the administration of some drugs, such as buflomedil and propionylcarnitine, opens new perspectives in the management of leg ischemia. In fact, the concept arises of an ischemic (exercise-dependent) or pharmacologic preconditioning in the treatment of patients with claudication.
Pasini
F L
FL
Institute of Medical Semeiotics, University of Siena, Italy.
Capecchi
P L
PL
Perri
T D
TD
D000241:Adenosine / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D000818:Animals; D006801:Humans; D007383:Intermittent Claudication / Q000503:physiopathology; D007511:Ischemia / Q000188:drug therapy / Q000503:physiopathology*; D019194:Ischemic Preconditioning; D007866:Leg / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D018919:Neovascularization, Physiologic / Q000502:physiology
D000241:Adenosine